Genprex
GNPX
17 hedge funds and large institutions have $3.64M invested in Genprex in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.
400% more call options, than puts
Call options by funds: $60K | Put options by funds: $12K
0% less ownership
Funds ownership: 0% → 0% (-0%)
6% less funds holding
Funds holding: 18 → 17 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
33% less capital invested
Capital invested by funds: $5.42M → $3.64M (-$1.79M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cypress Capital
Franklin,
Tennessee
|
+$74.4K |
| 2 |
Morgan Stanley
New York
|
+$37.2K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$37.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.77M |
| 2 |
BlackRock
New York
|
-$112K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$70.3K |
| 4 |
Renaissance Technologies
New York
|
-$47K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$37.2K |
GNPX Hedge Fund Activity: Q2 2023 in Review
17 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q2 2023, worth a combined $3.64M — down 33% from $5.42M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of GNPX and 3 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest buyer was Cypress Capital, opening a new position worth an estimated $74.4K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.77M sold.
- 17 institutional investors held Genprex (GNPX) as of Q2 2023, down from 18 in Q1 2023.
- Funds reported $3.64M of Genprex stock for Q2 2023, down 33% quarter-over-quarter.
- 3 funds opened new Genprex positions in Q2 2023 and 4 closed out, a net change of -1 holder.
- The largest Genprex buyer in Q2 2023 was Cypress Capital, an estimated $74.4K added.
- The largest Genprex seller in Q2 2023 was Armistice Capital, an estimated $1.77M sold.
Based on aggregated 13F filings for Q2 2023.